Search Results - "SANCLEMENTE, G"

What can we learn from psoriasis pharmacogenomics research? by Sanclemente, G.

“…Linked Article: van Vugt et al. Br J Dermatol 2018; 178:86–94…”
Get full text

Rasch Analysis Of The Dermatology Life Quality Index by Sanclemente, G., Mora, C., Aguirre, DC

“…Background and aims: Previous results of the Dermatology-Life-Quality-Index (DLQI) validation in Colombia based on the classical test theory (CTT) perspective…”
Get full text

Construct validity and responsiveness of Skindex‐29‐Colombia by Vasquez, D., Aguirre, D.‐C., Sanclemente, G.

“…Summary Until three decades ago, the understanding of disease and treatment effects on patients’ daily lives was very poor. More recently, and due to the fact…”
Get full text

[Translated article] Interventions for Basal Cell Carcinoma: Summary of Main Comparisons From a Cochrane Review and a Practical Interpretation of Findings by Sanclemente, G., Aguirre, D.C., Thomson, J.

“…Numerous surgical and nonsurgical modalities are available to treat basal cell carcinoma (BCC), but their true effectiveness and safety is unknown. This…”
Get full text

Interventions for Basal Cell Carcinoma: Summary of Main Comparisons From a Cochrane Review and a Practical Interpretation of Findings by Sanclemente, G, Aguirre, D C, Thomson, J

“…Numerous surgical and nonsurgical modalities are available to treat basal cell carcinoma (BCC), but their true effectiveness and safety is unknown. This…”
Get full text

Construct validity and responsiveness of the Colombian version of Skindex‐29 by Vasquez, D., Aguirre, D.‐C., Sanclemente, G.

“…Summary Background In recent years, the need for international, objective, patient‐reported outcomes measures has grown as international collaboration has…”
Get full text

Responsiveness of the Colombian Spanish Version of the DLQI in Psoriasis Patients With Biologic Therapy by Tibaduiza, M.F., Berbeo, Y.K., Ton, C.M., Aguirre-Acevedo, D.C., Sanclemente, G.

Get full text

Impact of Antibiotic Resistance on the Development of Recurrent and Relapsing Symptomatic Urinary Tract Infection in Kidney Recipients by Bodro, M., Sanclemente, G., Lipperheide, I., Allali, M., Marco, F., Bosch, J., Cofan, F., Ricart, M. J., Esforzado, N., Oppenheimer, F., Moreno, A., Cervera, C.

“…We sought to determine the frequency, risk factors, and clinical impact of recurrent urinary tract infections (UTI) in kidney transplant recipients. Of 867…”
Get full text

Impact of urinary tract infections on short-term kidney graft outcome by Bodro, M., Sanclemente, G., Lipperheide, I., Allali, M., Marco, F., Bosch, J., Cofan, F., Ricart, M.J., Esforzado, N., Oppenheimer, F., Moreno, A., Cervera, C.

“…Urinary tract infections (UTIs) are frequent after renal transplantation, but their impact on short-term graft outcome is not well established. All kidney…”
Get full text

Early Bacteremia After Solid Organ Transplantation by Linares, L, García-Goez, J.F, Cervera, C, Almela, M, Sanclemente, G, Cofán, F, Ricart, M.J, Navasa, M, Moreno, A

“…Abstract Objective Bloodstream infections (BSI) are a major cause of morbidity and mortality after solid organ transplantation. Our aim was to analyze early…”
Get full text

Mannose‐Binding Lectin–Deficient Donors Increase the Risk of Bacterial Infection and Bacterial Infection–Related Mortality After Liver Transplantation by Lombardo‐Quezada, J., Sanclemente, G., Colmenero, J., Español‐Rego, M., Arias, M. T., Ruiz, P., Mauro, E., Sastre, L., Crespo, G., Rimola, A., Moreno, A., Lozano, F., Navasa, M.

“…Mannose‐binding lectin (MBL) is synthesized by the liver and binds to microbes. MBL2 gene polymorphisms produce intermediate/low/null or normal MBL serum…”
Get full text

The impact of skin diseases on quality of life: A multicenter study by Sanclemente, G, Burgos, C, Nova, J, Hernández, F, González, C, Reyes, M I, Córdoba, N, Arévalo, Á, Meléndez, E, Colmenares, J, Ariza, S, Hernández, G

“…To date, no formal study has been published regarding how Colombian patients with skin disorders could be affected according to their perception of disease. To…”
Get full text

Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group by Philipp-Dormston, W.G., Sanclemente, G., Torezan, L., Tretti Clementoni, M., Le Pillouer-Prost, A., Cartier, H., Szeimies, R.M., Bjerring, P.

“…Conventional PDT (c‐PDT) is a widely used and approved non‐invasive treatment for actinic keratosis (AK). Recent clinical, histological and immunohistochemical…”
Get full text

In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis by Bueno, J. G., Martinez, C., Zapata, B., Sanclemente, G., Gallego, M., Mesa, A. C.

“…Summary Background.  Onychomycosis is one of the commonest dermatological diseases worldwide. The antifungal activity of current medications varies, and…”
Get full text

Epidemiology and risk factors for late infection in solid organ transplant recipients by Cervera, C., Fernández-Ruiz, M., Valledor, A., Linares, L., Antón, A., Ángeles Marcos, M., Sanclemente, G., Hoyo, I., Cofán, F., Ricart, M.J., Pérez-Villa, F., Navasa, M., Pumarola, T., Moreno, A.

“…C. Cervera, M. Fernández‐Ruiz, A. Valledor, L. Linares, A. Antón, M. Ángeles Marcos, G. Sanclemente, I. Hoyo, F. Cofán, M.J. Ricart, F. Pérez‐Villa, M. Navasa,…”
Get full text

Skindex‐29 量表哥伦比亚版的构念效度和反应性 by Vasquez, D., Aguirre, D.‐C., Sanclemente, G.

“…Summary 在三十年之前,人们对疾病和治疗对患者日常生活的影响了解很少。最近,由于国际科学合作的增多,尤其是患者报告结果 (PRO) 和生活质量 (QOL) 量表已成为根据患者观点评估任何药物的疗效的重要工具。但由于大多数 QOL…”
Get full text

Analysis of the Quality of Clinical Trials Published in Spanish-Language Dermatology Journals Between 1997 and 2012 by Sanclemente, G, Pardo, H, Sánchez, S, Bonfill, X

“…INTRODUCTIONThe value of randomized clinical trials (RCTs) undertaken to identify an association between an intervention and an outcome is determined by their…”
Get full text

Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients by Perez-Ordoño, L., Hoyo, I., Sanclemente, G., Ricart, M.J., Cofan, F., Perez-Villa, F., de la Bellacasa, J. Puig, Moreno, A., Cervera, C.

“…Anti‐Pneumocystis prophylaxis is recommended for at least 6–12 months after solid organ transplantation, as most cases of Pneumocystis jirovecii pneumonia…”
Get full text

Influence of Cytomegalovirus Disease in Outcome of Solid Organ Transplant Patients by Linares, L, Sanclemente, G, Cervera, C, Hoyo, I, Cofán, F, Ricart, M.J, Pérez-Villa, F, Navasa, M, Marcos, M.A, Antón, A, Pumarola, T, Moreno, A

“…Abstract Introduction Despite recent advances in prevention and treatment, cytomegalovirus (CMV) is still a major complication in transplant patients. This…”
Get full text

Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients by Bodro, M., Sanclemente, G., Crespo, G., Linares, L., Marcos, M.A., Marco, F., Miquel, R., Forns, X., Navasa, M., Moreno, A.

“…The aim of the study was to determine the clinical characteristics, frequency of opportunistic infections (OI), and the outcomes for liver transplant…”
Get full text